Home
Amylyx Pharmaceuticals AMLX paid Tarplin, Downs & Young $80K for lobbying in Q1 2023 · Medicare, Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $80,000
- Quarter
- Q1 2023
- Client
- Amylyx Pharmaceuticals
- Reported
- 23/04/19
Up 0.0% from last quarter
What else happened in Amylyx Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 23/03/01~23/04/30Amylyx Pharmaceuticals's other lobbying reports
- Amylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
AMLX
$40K
$40K
Reported 07/16
for Q2
- Amylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
AMLX
$40K
$40K
Reported 04/20
for Q1
- Amylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
AMLX
$40K
$40K
Reported 01/20
for Q4 2025
- Amylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
AMLX
$40K
$40K
Reported 25/10/16
for Q3 2025
- Amylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
AMLX
$40K
$40K
Reported 25/07/16
for Q2 2025